✦ LIBER ✦

B22956/1, a New Intravascular Contrast Agent for MRI

✍ Scribed by Noce, Anna La; Stoelben, S.; Scheffler, K.; Hennig, J.; Lenz, H.Maier; Ferla, R.La; Lorusso, V.; Maggioni, F.; Cavagna, F.

Book ID: 123040388
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 82 KB
Volume: 9
Category: Article
ISSN: 1076-6332
DOI: 10.1016/S1076-6332(03)80245-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical Profile and Clinical Potenti

Preclinical Profile and Clinical Potential of Gadocoletic Acid Trisodium Salt (B22956/1), a New Intravascular Contrast Medium for MRI

✍ Cavagna, Friedrich M.; Lorusso, Vito; Anelli, Pier Lucio; Maggioni, Fabio; de Ha 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 151 KB

MRI monitoring of Avastin™ antiangiogene

MRI monitoring of Avastin™ antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer

✍ Anda Preda; Viktor Novikov; Martina Möglich; Karl Turetschek; David M. Shames; R 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB

## Abstract ## Purpose To evaluate the diagnostic and prognostic potential of a new protein‐binding contrast medium, B22956/1, for quantitatively characterizing tumor microvessels by MRI and monitoring response to antiangiogenic therapy. ## Materials and Methods Dynamic contrast‐enhanced MRI (DC

Sucrose polyester: A new oral contrast a

Sucrose polyester: A new oral contrast agent for MRI

✍ Ray Ballinger; Richard L. Magin; Andrew G. Webb 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

## Abstract Sucrose polyester (a dietary fat substitute) opacifies the entire gastrointestinal tract of the rat with oral administration in magnetic resonance imaging (MRI). These results suggest the potential use of this material as an oral contrast agent for human abdominal MRI studies. © 1991 Ac

Three-dimensional MR pulmonary perfusion

Three-dimensional MR pulmonary perfusion imaging and angiography with an injection of a new blood pool contrast agent B-22956/1

✍ Jie Zheng; James Carr; Katherine Harris; Mark B. Saker; Friedrich M. Cavagna; Fa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 1 views

## Abstract Initial evaluation of a new blood pool agent, B‐22956/1, for pulmonary imaging was performed in five domestic pigs with artificial embolism. Pre‐embolism 3D pulmonary perfusion images were first acquired by injecting an extravascular agent, gadoteridol. The pulmonary arteries of the pig

A new macrocyclic MRI contrast agent: Gd

A new macrocyclic MRI contrast agent: Gd MCTA complex

✍ Michel Schaefer; Dominique Meyer; Sylvie Beaute; Didier Doucet 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

Contrast-enhanced MRI of murine sponge m

Contrast-enhanced MRI of murine sponge model for progressive angiogenesis assessed with gadoteridol (ProHance) and gadocoletic acid trisodium salt (B22956/1)

✍ Simona Ramponi; Cristina Rebaudengo; Claudia Cabella; Adriana Grotti; Stefania V 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 896 KB

## Abstract ## Purpose To investigate the potential value of MRI for noninvasive assessment of angiogenesis in a murine model exploiting the properties of two contrast agents, gadoteridol (ProHance) and gadocoletic acid trisodium salt (B22956/1). ## Materials and Methods Biocompatible sponges we